The Endocrine Society's position is clear: FDA-approved bioidentical hormones (such as Estrace, Prometrium, or transdermal estradiol patches) should be preferred over custom-compounded formulations because approved products undergo standardized manufacturing and quality control [9]
With semaglutide (at its authorized obesity dose), many patients in trials lost around 14-15% of starting body weight over ~68-72 weeks vs placebo
Common issues include: (1) Card not activated activate at lillycardactivation.com first, (2) Pharmacy processing it as primary instead of secondary payer, (3) Prior authorization not yet approved by your insurance, (4) Government insurance detected in the system
They want clear expectations, safety, and real medical guidance
Exploration of measures to prevent acute high altitude diseases during rapid high altitude labor operations
It is not approved for human consumption, medical, or veterinary use